Evidence map›Paper›PMID 34926968›Full record

ArticleACS omega2021

Identification of SARS-CoV-2 Proteins from Nasopharyngeal Swabs Probed by Multiple Reaction Monitoring Tandem Mass Spectrometry.

Gabriella Pinto, Anna Illiano, Veronica Ferrucci, Fabrizio Quarantelli, Carolina Fontanarosa, Roberto Siciliano, Carmela Di Domenico, Barbara Izzo, Piero Pucci, Gennaro Marino and 2 more

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. CovAnalytical chemistry · 2022
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Gabriella PintoDepartment of Chemical Sciences, University of Naples Federico II, Via Cinthia 26, 80126 Naples, Italy.ORCID https://orcid.org/0000-0001-9169-3452
Anna IllianoDepartment of Chemical Sciences, University of Naples Federico II, Via Cinthia 26, 80126 Naples, Italy.ORCID https://orcid.org/0000-0003-1491-8966
Veronica FerrucciCEINGE Advanced Biotechnology, Via Gaetano Salvatore 486, 80145 Naples, Italy.
Fabrizio QuarantelliCEINGE Advanced Biotechnology, Via Gaetano Salvatore 486, 80145 Naples, Italy.
Carolina FontanarosaDepartment of Chemical Sciences, University of Naples Federico II, Via Cinthia 26, 80126 Naples, Italy.
Roberto SicilianoCEINGE Advanced Biotechnology, Via Gaetano Salvatore 486, 80145 Naples, Italy.
Carmela Di DomenicoCEINGE Advanced Biotechnology, Via Gaetano Salvatore 486, 80145 Naples, Italy.
Barbara IzzoCEINGE Advanced Biotechnology, Via Gaetano Salvatore 486, 80145 Naples, Italy.
Piero PucciDepartment of Chemical Sciences, University of Naples Federico II, Via Cinthia 26, 80126 Naples, Italy.
Gennaro MarinoDepartment of Chemical Sciences, University of Naples Federico II, Via Cinthia 26, 80126 Naples, Italy.
Massimo ZolloCEINGE Advanced Biotechnology, Via Gaetano Salvatore 486, 80145 Naples, Italy.
Angela AmoresanoDepartment of Chemical Sciences, University of Naples Federico II, Via Cinthia 26, 80126 Naples, Italy.
Ceinge Biotecnologie Avanzate (Italy) · ITIstituto Nazionale Biostrutture e Biosistemi · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous reverse transcription polymerase chain reaction (RT-PCR) tests have emerged over the past year as the gold standard for detecting millions of cases of SARS-CoV-2 reported daily worldwide. However, problems with critical shortages of key reagents such as PCR primers and RNA extraction kits and unpredictable test reliability related to high viral replication cycles have triggered the need for alternative methodologies to PCR to detect specific COVID-19 proteins. Several authors have developed methods based on liquid chromatography with tandem mass spectrometry (LC-MS/MS) to confirm the potential of the technique to detect two major proteins, the spike and the nucleoprotein, of COVID-19. In the present work, an S-Trap mini spin column digestion protocol was used for sample preparation prodromal to LC-MS/MS analysis in multiple reactions monitoring ion mode (MRM) to obtain a comprehensive method capable of detecting different viral proteins. The developed method was applied to n. 81 oro/nasopharyngeal swabs submitted in parallel to quantitative reverse transcription PCR (RT-qPCR) assays to detect RdRP, the S and N genes specific for COVID-19, and the E gene for all

Identifiers

PMID34926968
PMCPMC8672425
OpenAlexW4200517531

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.